バンコマイシン耐性腸球菌フェシウム薬の世界市場（～2026年）

• 英文タイトル：Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY05444 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はバンコマイシン耐性腸球菌フェシウム薬のグローバル市場について調査・分析したレポートです。種類別（ダプトマイシン、リネゾリド、キヌプリスチン/ダルホプリスチン、アンピシリン、クロラムフェニコール、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バンコマイシン耐性腸球菌フェシウム薬の競争状況、市場シェア ・世界のバンコマイシン耐性腸球菌フェシウム薬市場：種類別市場規模 2015年-2020年（ダプトマイシン、リネゾリド、キヌプリスチン/ダルホプリスチン、アンピシリン、クロラムフェニコール、その他） ・世界のバンコマイシン耐性腸球菌フェシウム薬市場：種類別市場規模予測 2021年-2026年（ダプトマイシン、リネゾリド、キヌプリスチン/ダルホプリスチン、アンピシリン、クロラムフェニコール、その他） ・世界のバンコマイシン耐性腸球菌フェシウム薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のバンコマイシン耐性腸球菌フェシウム薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のバンコマイシン耐性腸球菌フェシウム薬市場分析：米国、カナダ ・ヨーロッパのバンコマイシン耐性腸球菌フェシウム薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバンコマイシン耐性腸球菌フェシウム薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバンコマイシン耐性腸球菌フェシウム薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバンコマイシン耐性腸球菌フェシウム薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alchemia Limited、Alvogen、Aphios Corporation、Cellceutix Corporation、Enanta Pharmaceuticals、Helix BioMedix、LegoChem Biosciences、Lytix Biopharma、MGB Biopharma Limited、Microbiotix ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market
The global Drugs for Vancomycin-Resistant Enterococcus Faecium market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Drugs for Vancomycin-Resistant Enterococcus Faecium Scope and Market Size
Drugs for Vancomycin-Resistant Enterococcus Faecium market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Vancomycin-Resistant Enterococcus Faecium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Drugs for Vancomycin-Resistant Enterococcus Faecium market is segmented into
Daptomycin
Linezolid
Quinupristin/dalfopristin
Ampicillin
Chloramphenicol
Others

Segment by Application, the Drugs for Vancomycin-Resistant Enterococcus Faecium market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Drugs for Vancomycin-Resistant Enterococcus Faecium market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drugs for Vancomycin-Resistant Enterococcus Faecium market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Analysis
Drugs for Vancomycin-Resistant Enterococcus Faecium market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drugs for Vancomycin-Resistant Enterococcus Faecium business, the date to enter into the Drugs for Vancomycin-Resistant Enterococcus Faecium market, Drugs for Vancomycin-Resistant Enterococcus Faecium product introduction, recent developments, etc.

The major vendors covered:
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix

レポート目次

---

1 Study Coverage
1.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
1.2 Market Segments
1.3 Key Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by Type
1.4.2 Daptomycin
1.4.3 Linezolid
1.4.4 Quinupristin/dalfopristin
1.4.5 Ampicillin
1.4.6 Chloramphenicol
1.4.7 Others
1.5 Market by Application
1.5.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, Estimates and Forecasts
2.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue 2015-2026
2.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales 2015-2026
2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Competitor Landscape by Players
3.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Manufacturers
3.1.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Manufacturers (2015-2020)
3.1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Manufacturers (2015-2020)
3.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Manufacturers
3.2.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Manufacturers (2015-2020)
3.2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in 2019
3.2.5 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Manufacturers
3.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturing Base Distribution, Product Types
3.4.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type
3.4.3 Date of International Manufacturers Enter into Drugs for Vancomycin-Resistant Enterococcus Faecium Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2015-2020)
4.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020)
4.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Type (2015-2020)
4.1.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Type (2021-2026)
4.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Type (2021-2026)
4.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Type (2021-2026)
4.2.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2015-2020)
5.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020)
5.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Application (2015-2020)
5.1.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Application (2015-2020)
5.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Application (2021-2026)
5.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Application (2021-2026)
5.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Application (2021-2026)
5.2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price Forecast by Application (2021-2026)

6 North America
6.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium by Country
6.1.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country
6.1.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Type
6.3 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Application

7 Europe
7.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium by Country
7.1.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country
7.1.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Type
7.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium by Region
8.1.1 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Region
8.1.2 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Type
8.3 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Application

9 Latin America
9.1 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium by Country
9.1.1 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country
9.1.2 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Type
9.3 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium by Country
10.1.1 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country
10.1.2 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Type
10.3 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Facts & Figures by Application

11 Company Profiles
11.1 Alchemia Limited
11.1.1 Alchemia Limited Corporation Information
11.1.2 Alchemia Limited Description and Business Overview
11.1.3 Alchemia Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.1.5 Alchemia Limited Related Developments
11.2 Alvogen
11.2.1 Alvogen Corporation Information
11.2.2 Alvogen Description and Business Overview
11.2.3 Alvogen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.2.5 Alvogen Related Developments
11.3 Aphios Corporation
11.3.1 Aphios Corporation Corporation Information
11.3.2 Aphios Corporation Description and Business Overview
11.3.3 Aphios Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.3.5 Aphios Corporation Related Developments
11.4 Cellceutix Corporation
11.4.1 Cellceutix Corporation Corporation Information
11.4.2 Cellceutix Corporation Description and Business Overview
11.4.3 Cellceutix Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.4.5 Cellceutix Corporation Related Developments
11.5 Enanta Pharmaceuticals
11.5.1 Enanta Pharmaceuticals Corporation Information
11.5.2 Enanta Pharmaceuticals Description and Business Overview
11.5.3 Enanta Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.5.5 Enanta Pharmaceuticals Related Developments
11.6 Helix BioMedix
11.6.1 Helix BioMedix Corporation Information
11.6.2 Helix BioMedix Description and Business Overview
11.6.3 Helix BioMedix Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.6.5 Helix BioMedix Related Developments
11.7 LegoChem Biosciences
11.7.1 LegoChem Biosciences Corporation Information
11.7.2 LegoChem Biosciences Description and Business Overview
11.7.3 LegoChem Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.7.5 LegoChem Biosciences Related Developments
11.8 Lytix Biopharma
11.8.1 Lytix Biopharma Corporation Information
11.8.2 Lytix Biopharma Description and Business Overview
11.8.3 Lytix Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.8.5 Lytix Biopharma Related Developments
11.9 MGB Biopharma Limited
11.9.1 MGB Biopharma Limited Corporation Information
11.9.2 MGB Biopharma Limited Description and Business Overview
11.9.3 MGB Biopharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.9.4 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.9.5 MGB Biopharma Limited Related Developments
11.10 Microbiotix
11.10.1 Microbiotix Corporation Information
11.10.2 Microbiotix Description and Business Overview
11.10.3 Microbiotix Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.10.5 Microbiotix Related Developments
11.1 Alchemia Limited
11.1.1 Alchemia Limited Corporation Information
11.1.2 Alchemia Limited Description and Business Overview
11.1.3 Alchemia Limited Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
11.1.5 Alchemia Limited Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Estimates and Projections by Region
12.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Regions 2021-2026
12.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Regions 2021-2026
12.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast (2021-2026)
12.2.1 North America: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast (2021-2026)
12.2.2 North America: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast (2021-2026)
12.2.3 North America: Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2021-2026)
12.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast (2021-2026)
12.3.1 Europe: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast (2021-2026)
12.3.2 Europe: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast (2021-2026)
12.3.3 Europe: Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Region (2021-2026)
12.5 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast (2021-2026)
12.5.1 Latin America: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast (2021-2026)
12.5.2 Latin America: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast (2021-2026)
12.5.3 Latin America: Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Drugs for Vancomycin-Resistant Enterococcus Faecium Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segments
Table 2. Ranking of Global Top Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Daptomycin
Table 5. Major Manufacturers of Linezolid
Table 6. Major Manufacturers of Quinupristin/dalfopristin
Table 7. Major Manufacturers of Ampicillin
Table 8. Major Manufacturers of Chloramphenicol
Table 9. Major Manufacturers of Others
Table 10. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Regions (2015-2020)
Table 14. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Manufacturers (2015-2020)
Table 17. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Drugs for Vancomycin-Resistant Enterococcus Faecium by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium as of 2019)
Table 19. Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Drugs for Vancomycin-Resistant Enterococcus Faecium Price (2015-2020) (USD/Pcs)
Table 22. Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type
Table 24. Date of International Manufacturers Enter into Drugs for Vancomycin-Resistant Enterococcus Faecium Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020) (K Pcs)
Table 27. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Type (2015-2020)
Table 28. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Type (2015-2020)
Table 30. Drugs for Vancomycin-Resistant Enterococcus Faecium Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020) (K Pcs)
Table 32. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Application (2015-2020)
Table 33. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country (2015-2020) (K Pcs)
Table 34. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country (2015-2020)
Table 35. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country (2015-2020)
Table 37. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020) (K Pcs)
Table 38. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type (2015-2020)
Table 39. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020) (K Pcs)
Table 40. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2015-2020)
Table 41. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country (2015-2020)
Table 43. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country (2015-2020)
Table 45. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type (2015-2020)
Table 47. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2015-2020)
Table 57. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country (2015-2020)
Table 61. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type (2015-2020)
Table 63. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2015-2020)
Table 73. Alchemia Limited Corporation Information
Table 74. Alchemia Limited Description and Major Businesses
Table 75. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Alchemia Limited Product
Table 77. Alchemia Limited Recent Development
Table 78. Alvogen Corporation Information
Table 79. Alvogen Description and Major Businesses
Table 80. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Alvogen Product
Table 82. Alvogen Recent Development
Table 83. Aphios Corporation Corporation Information
Table 84. Aphios Corporation Description and Major Businesses
Table 85. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Aphios Corporation Product
Table 87. Aphios Corporation Recent Development
Table 88. Cellceutix Corporation Corporation Information
Table 89. Cellceutix Corporation Description and Major Businesses
Table 90. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Cellceutix Corporation Product
Table 92. Cellceutix Corporation Recent Development
Table 93. Enanta Pharmaceuticals Corporation Information
Table 94. Enanta Pharmaceuticals Description and Major Businesses
Table 95. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Enanta Pharmaceuticals Product
Table 97. Enanta Pharmaceuticals Recent Development
Table 98. Helix BioMedix Corporation Information
Table 99. Helix BioMedix Description and Major Businesses
Table 100. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Helix BioMedix Product
Table 102. Helix BioMedix Recent Development
Table 103. LegoChem Biosciences Corporation Information
Table 104. LegoChem Biosciences Description and Major Businesses
Table 105. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. LegoChem Biosciences Product
Table 107. LegoChem Biosciences Recent Development
Table 108. Lytix Biopharma Corporation Information
Table 109. Lytix Biopharma Description and Major Businesses
Table 110. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Lytix Biopharma Product
Table 112. Lytix Biopharma Recent Development
Table 113. MGB Biopharma Limited Corporation Information
Table 114. MGB Biopharma Limited Description and Major Businesses
Table 115. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. MGB Biopharma Limited Product
Table 117. MGB Biopharma Limited Recent Development
Table 118. Microbiotix Corporation Information
Table 119. Microbiotix Description and Major Businesses
Table 120. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Microbiotix Product
Table 122. Microbiotix Recent Development
Table 123. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Regions (2021-2026) (K Pcs)
Table 124. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. North America: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Europe: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Region (2021-2026) (K Pcs)
Table 132. Asia Pacific: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Latin America: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. Middle East and Africa: Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Drugs for Vancomycin-Resistant Enterococcus Faecium Players
Table 141. Drugs for Vancomycin-Resistant Enterococcus Faecium Customers List
Table 142. Drugs for Vancomycin-Resistant Enterococcus Faecium Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Product Picture
Figure 2. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type in 2020 & 2026
Figure 3. Daptomycin Product Picture
Figure 4. Linezolid Product Picture
Figure 5. Quinupristin/dalfopristin Product Picture
Figure 6. Ampicillin Product Picture
Figure 7. Chloramphenicol Product Picture
Figure 8. Others Product Picture
Figure 9. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Drugs for Vancomycin-Resistant Enterococcus Faecium Report Years Considered
Figure 14. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size 2015-2026 (US$ Million)
Figure 15. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales 2015-2026 (K Pcs)
Figure 16. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Region (2015-2020)
Figure 18. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Region in 2019
Figure 19. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Region (2015-2020)
Figure 20. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Region in 2019
Figure 21. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in 2019
Figure 23. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type (2015-2020)
Figure 25. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type in 2019
Figure 26. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Type (2015-2020)
Figure 27. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Type in 2019
Figure 28. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Price Range (2015-2020)
Figure 29. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2015-2020)
Figure 30. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application in 2019
Figure 31. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Application (2015-2020)
Figure 32. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Application in 2019
Figure 33. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country in 2019
Figure 36. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country in 2019
Figure 37. U.S. Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type in 2019
Figure 42. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application in 2019
Figure 43. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country in 2019
Figure 46. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country in 2019
Figure 47. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type in 2019
Figure 58. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application in 2019
Figure 59. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Region in 2019
Figure 62. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Region in 2019
Figure 63. China Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type in 2019
Figure 86. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application in 2019
Figure 87. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country in 2019
Figure 90. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country in 2019
Figure 91. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type in 2019
Figure 98. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application in 2019
Figure 99. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Country in 2019
Figure 103. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type in 2019
Figure 110. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application in 2019
Figure 111. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---